Smad3 mutant mice develop colon cancer with overexpression of COX-2

Yu-Ping Zhu1, Zhuo Liu1, Zhi-Xuan Fu1

  • 1Department of Colorectal Cancer Surgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.

Oncology Letters
|April 30, 2017
PubMed

Insights

This study investigated cyclooxygenase-2 (COX-2) in Smad3 mutant mice, which develop colon cancer. Results show a link between Smad3 mutation, colon cancer development, and COX-2 overexpression.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Colon cancer is a leading cause of cancer mortality.
  • Smad3 mutant mice are a model for colon cancer development.
  • Cyclooxygenase-2 (COX-2) is implicated in various cancers.

Purpose of the Study:

  • To elucidate the role of COX-2 in Smad3 mutant mice.
  • To investigate the correlation between Smad3 mutation, colon cancer, and COX-2 expression.
  • To identify the expression patterns of COX-2 in this colon cancer model.

Main Methods:

  • Generation of homozygous Smad3 (-/-) mutant mice.
  • Immunohistochemistry using COX-2 antibody.
  • Validation of results with reverse transcription-polymerase chain reaction (RT-PCR).

Main Results:

  • Successfully generated homozygous Smad3 mutant mice.
  • Identified an overexpression pattern of COX-2 in these mice.
  • Demonstrated a significant link between Smad3 mutation, colon cancer, and COX-2.

Conclusions:

  • Smad3 mutation is associated with colon cancer development in mice.
  • Overexpression of COX-2 is a key feature in Smad3 mutant mice with colon cancer.
  • COX-2 plays a role in the pathogenesis of colon cancer in this genetic model.